Arkema showcases at the CPhI 2014 trade show, the world's leading pharmaceutical event, in Paris - Villepinte from October 7 to 9, its whole range of pharmaceutical and chemical industry intermediates: 

  • Hydrazine hydrate and its derivatives used as intermediates in the synthesis of active ingredients for the production of various medecines,
  • Amines (Hüning base ethylamines, isopropylamines and other custom manufactured specialty amines) used as reactants, intermediates, extraction solvents, acid scavengers and neutralizing agents in the synthesis of active ingredients.
  • Oxygenated solvents derived from acetone mainly used as intermediates for pharmaceutical and agrochemical industries. Some of them can be used for formulation in emulsifiable concentrates allowing to prepare clear and stable emulsions.
  • Thiochemical derivatives, including:

. DMSO (dimethyl sulfoxide) widely used as a reaction solvent in pharmaceutical synthesis and as a cleaning agent,

. The sulfonyl range including methane sulfonic acid particularly well suited to API preparation in its anhydrous form, and as an acid catalyst in its aqueous form,

. The methane sulfonyl chloride as a synthesis intermediate,

. The thioacetic acid as a synthesis intermediate for the preparation of  thioacetate and mercaptans of high purity.

  • The Fluorinated Specialties range including catalysts like BF3 (Boron Trifluoride), high purity HCl (Anhydrous Hydrogen Chloride) and other Fluorochemicals used as intermediates for Pharmaceutical & Agrochemical industries
  • And the activated carbons range from CECA for the purification, decolorization and filtration of Active Pharmaceutical ingredients (API) and intermediates. Marketed under the trade names Acticarbone® and Anticromos®, these products are renowned worldwide for its exceptionally constant top-rate performance and high purity level.

Visit Arkema's Stand 3H34 (Hall 3)

Arkema will give a conference the 7/10 at 15.30 on the topic "Custom Fluorinated synthons enabling the production of new advance intermediates for pharmaceutical and agricultural chemical applications".

A global chemical company and France's leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generatesannual revenue of approximately €6.1 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.

distributed by